Drug Topics

FEBRUARY 21, 2024

How much longer can independent pharmacists survive with the current method of reimbursement?

275

275

STAT

FEBRUARY 21, 2024

Alison Sbrana was in the belly of an opera when her life changed. Down in the pit, surrounded by fellow orchestra members, she’d been straining to play her flute for half the show. As performers overhead enveloped the audience in arias, Sbrana felt like the Hulk was pulling on the tendons in the right side of her neck. “I begged anybody for meds at intermission,” she said.

Immunization 145

Immunization 145

Drug Topics

FEBRUARY 21, 2024

The novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.

FDA 187

FDA 187

STAT

FEBRUARY 21, 2024

SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of fog blanketing the San Francisco skyline. Its warmth did not reach the operating room tucked into the sprawling Parnassus Heights hospital complex. In there, the light was all cold and blue fluorescence washing over the sea of scrub caps huddled around an anesthetized young woman on a gurney.

Hospitals 145

Hospitals 145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

FEBRUARY 21, 2024

Offering services such as point-of-care testing and bundled products marketed as recovery kits can increase customer loyalty.

152

152

STAT

FEBRUARY 21, 2024

People with autoimmune disorders don’t usually get to talk about a cure. There’s symptom management, hopeful periods of remission often followed by relapses, but rarely a lasting fix for the way their immune system attacks healthy cells. If the immune system is an army, then those with conditions like lupus, multiple sclerosis, or rheumatoid arthritis are often fighting a never-ending war of friendly fire.

Immunization 144

Immunization 144

STAT

FEBRUARY 21, 2024

Antivenom, like Mexican Coke or grandma’s cookies, is still made the old-fashioned way. In antivenom’s case, the recipe is straightforward: Pump a horse full of sub-lethal doses of venom from various local snakes, wait for them to develop an immune response, tap their blood, purify out antibodies, bottle, and freeze. This vampiric, century-old process still reigns because of the unique scientific challenge posed by snake venoms.

Immunization 141

Immunization 141

Fierce Healthcare

FEBRUARY 21, 2024

Given the impact that social factors have on overall health, employers can better manage costs and outcomes by embracing deeper, population-level data analysis, according to a new white paper. | Given the impact that social factors have on overall health, employers can better manage costs and outcomes by embracing deeper, population-level data analysis, according to a new white paper.

128

128

STAT

FEBRUARY 21, 2024

When I accompany my father to his regular cardiologist appointment in Puerto Rico, worry and sadness always come along with us. While treatment has kept his health stable, I am still troubled that he always has to ask his doctor for medication samples. If he lived in any of the 50 states, Medicare would have provided coverage for his medical needs. But because he lived in Puerto Rico, Medicare is far less useful to him.

Insurance 140

Insurance 140

Fierce Pharma

FEBRUARY 21, 2024

On the heels of a turbulent 2023 in which Novavax’s very existence was at stake, the beleaguered vaccine maker has new reason to be optimistic about the future. | Novavax has reached a settlement with Gavi, the Vaccine Alliance ending arbitration tied to a 2021 advance purchase agreement around its prototype COVID-19 vaccine NVX-CoV2373. Had Novavax lost the arbitration, the company might have had to refund nearly $700 million.

Vaccines 124

Vaccines 124

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

FEBRUARY 21, 2024

Usually the words generative AI in health are followed by a bold claim. The technology will transform some aspect of care delivery, save gobs of money, or automate administrative tasks crucial to connecting patients with timely services. Rohit Chandra, chief digital officer of the Cleveland Clinic, said generative AI can accomplish all these things.

Hospitals 138

Hospitals 138

Fierce Pharma

FEBRUARY 21, 2024

In a year that started with more than two-thirds of biopharma companies posting | While Novo Nordisk and Eli Lilly continued to be the biopharma industry growth leaders in the fourth quarter of 2023, many other drugmakers also delivered big gains, including Daiichi Sankyo, Amgen, Teva, GSK and Novartis.

123

123

pharmaphorum

FEBRUARY 21, 2024

Explore the evolution of clinical research in the UK, including the role of NIHR and Direct Delivery Teams in embracing new delivery models. Join our informative webinar to learn more.

122

122

Pharmacy Times

FEBRUARY 21, 2024

National governments and global non-governmental organizations are trying to expand access to essential medicines and treatments in developing countries.

122

122

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

FEBRUARY 21, 2024

Four major drugmakers are joining forces as they prepare to battle certain aspects of the Inflation Reduction Act (IRA) in court next month. | A federal judge in New Jersey agreed to let Bristol Myers Squibb, Novo Nordisk, Novartis and J&J present oral arguments together in their bid to challenge the government's new Medicare negotiations framework.

112

112

Pharmacy Times

FEBRUARY 21, 2024

Teclistamab was previously approved in October 2022 for the treatment of adult patients with relapsed or refractory multiple myeloma who received at least 4 prior therapies.

FDA 117

FDA 117

Pharmaceutical Commerce

FEBRUARY 21, 2024

Cabenuva (cabotegravir + rilpivirine) showed superior efficacy in maintaining viral load suppression in patients with HIV compared with standard of care daily oral antiretroviral treatment.

111

111

Pharmacy Times

FEBRUARY 21, 2024

Investigators suggested that this difference is caused by a common medication for treatment-resistant schizophrenia.

132

132

Fierce Healthcare

FEBRUARY 21, 2024

Medicare Advantage (MA) beneficiaries are more likely than traditional Medicare enrollees to experience delays in care while they wait for prior authorization approval, but MA members are likely to | Medicare Advantage and traditional Medicare enrollees experience similar access to services and similar challenges, a report from the Commonwealth Fund concluded.

110

110

pharmaphorum

FEBRUARY 21, 2024

Attention-deficit hyperactivity disorder (ADHD) in adults is not well understood and highly underdiagnosed, but the developers of a mobile game designed to raise awareness hope to shine a light on the struggles of people struggling with the condition.

110

110

Fierce Pharma

FEBRUARY 21, 2024

Joseph Papa has reemerged nearly a year after stepping down as head honcho of Bausch + Lomb. | Joseph Papa has re-emerged nearly a year after stepping down as head honcho of Bausch + Lomb. The former Valeant helmsman is now tasked with turning around Emergent BioSolutions as its new CEO.

107

107

STAT

FEBRUARY 21, 2024

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

106

106

Fierce Pharma

FEBRUARY 21, 2024

Following the exodus of several prominent drugmakers and some surprising drug pricing setbacks in Washington, the influential industry lobbying group PhRMA has been busy navigating new challen | PhRMA revealed that Gilead CEO Daniel O’Day has donned the mantle as chair of the board of directors, replacing Novartis chief Vas Narasimhan, who held the position for much of 2023.

106

106

The Checkup by Singlecare

FEBRUARY 21, 2024

Pregnancy can be an exciting time, but it’s not without an unpleasant side effect or two. Up to half of pregnant women experience gastroesophageal reflux disease (GERD) , also known as indigestion or heartburn. There are many medications and natural remedies for acid reflux. Prilosec ( omeprazole ) is a commonly used over-the-counter (OTC) heartburn medication.

FDA 105

FDA 105

Drug Store News

FEBRUARY 21, 2024

DSN spoke to Laura Geller about its "Let’s Face It” campaign, the 20th anniversary of the Baked Balance-n-Brighten Color Correcting Foundation and a new summer product launch.

105

105

The Checkup by Singlecare

FEBRUARY 21, 2024

Pantoprazole, also known by the brand name Protonix, is used to prevent and treat stomach ulcers and gastroesophageal reflux disease (GERD). GERD is a medical condition that occurs when there is a backflow of stomach acidic content into the esophagus (also called acid reflux), causing heartburn, injury to the lining of the esophagus, and other gastrointestinal symptoms.

105

105

Drug Store News

FEBRUARY 21, 2024

Recent data from YouGov Profiles reveals that nearly half of Americans (47%) buy OTC drugs as required rather than stocking up, followed by 39% who keep a stock of medications but buy others when necessary.

105

105

Board Vitals - Pharmacist

FEBRUARY 21, 2024

Medical residents play an important role in healthcare, from providing patient care to conducting research and collaborating with healthcare teams. To honor residents and their contributions and sacrifices, we celebrate Thank a Resident Day—a day dedicated to expressing gratitude for these remarkable individuals. What is Thank a Resident Day? Medical residency is a demanding journey filled with long hours, challenging cases, and constant learning.

Patient Care 105

Patient Care Medical Schools 105

Fierce Healthcare

FEBRUARY 21, 2024

Medicaid disproportionate share hospital (DSH) payments are being cut by $8 billion annually during the current and next four federal fiscal years under a new Centers for Medicare and Medicaid Serv | Published Tuesday and set to go into effect in two months, the final rule limits the calculation of a hospitals Medicaid shortfall to beneficiaries with Medicaid as their primary payer.

Hospitals 104

Hospitals 104

pharmaphorum

FEBRUARY 21, 2024

FDA and EMA start speedy reviews of Servier’s vorasidenib for IDH-mutated low-grade glioma, hoping to end decades of stagnation in therapies for the brain cancer.

FDA 108

FDA 108

Drug Store News

FEBRUARY 21, 2024

Aetna Better Health of Illinois is hosting Community Health Councils and introducing new benefits to eliminate barriers to achieving better physical and mental health.

105

105

pharmaphorum

FEBRUARY 21, 2024

United sues FDA for allowing a marketing application for a competitor to its top-seller Tyvaso, filed by Liquidia, that sidesteps established procedures

FDA 110

FDA 110

STAT

FEBRUARY 21, 2024

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case? In utero gene editing , or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby pr

100

100

Drug Topics

FEBRUARY 21, 2024

Dr. Daled Serrano-Bahri, PharmD, is the associate director of MSL Training, and Inflammation & Autoimmunity at Incyte.

98

98